Clinical, morphological and molecular genetic characteristics in patients with bilateral kidney tumors
Pediatric Hematology/Oncology and Immunopathology · 14.04.2026 · 25 (1) · 114-130
DOI: 10.24287/j.1058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Hematology/Oncology and Immunopathology, online erschienen am 14.04.2026. Verfasst von G. B. Sagoyan und 7 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Bilateral kidney tumors (BKT) in patients with nephroblastoma is a relatively rare clinical situation and a more complex treatment challenge. The aim of the study was to evaluate the clinical, morphological, and molecular genetic characteristics of patients with BKT. Materials and methods. A retrospective analysis was conducted of 30 patients aged 2.4 to 56.2 months with histologically confirmed nephroblastoma/nephroblastomatosis treated at the Blokhin National Medical Research Center of Oncology from September 1, 2019, to June 1, 2024. Clinical and morphological features, molecular genetic characteristics, the presence of predisposing conditions, and the extent of surgical intervention were examined.
Results
The median age at diagnosis in patients with and without tumor predisposition syndrome (PS) was 25 months (range, 2.4–56.2 months) and 30 months (range, 12.6–51.1 months), respectively. The female:male ratio was 1.5:1. In 23/29 (79,3%) patients with BKT, based on molecular genetic studies, germinal mutations in genes and epigenetic disorders were detected (in most cases, mutations in the WT1 and TRIM28 genes were detected and the Beckwith–Wiedemann syndrome spectrum was diagnosed). A statistically significant effect of the histological variant of nephroblastoma and PS was observed: WT1 patients had predominantly stromal histology, TRIM28 patients had epithelial histology, and patients with Beckwith–Wiedemann syndrome spectrum had predominantly regressive nephroblastoma (p 0.001). In 70% of cases, the main clinical sign indicating a renal tumor was abdominal enlargement and/or the presence of a tumor in the abdominal cavity. Stage V disease was diagnosed in 80% of children, and stage IV (metastatic lung disease) in 20%. After 6 weeks of VA therapy, 12/30 (40%) patients required additional courses of polychemotherapy using the VA and Carbo/Eto regimens according to the UMBRELLA SIOP-RTSG 2016 protocol. In 2/12 (16.7%) patients, negative dynamics were observed with tumor growth during specialized treatment; both patients had bilateral stromal nephroblastoma. Surgical treatment in most cases involved bilateral nephron-sparing surgery (22/30; 73.3%), and only 6 cases were microscopically classified as R1 resections. The local stage at which the patient subsequently received therapy was stage I in most cases (60%). Three-year overall survival and event-free survival were 93.3% and 87.8%, respectively. Four events were recorded: one local recurrence and three deaths (one due to disease progression, one due to infectious complications, and one due to early postoperative pulmonary embolism).
Conclusions
BKT is a rare condition requiring a multidisciplinary approach. Additional courses of chemotherapy according to the UMBRELLA SIOP-RTSG 2016 protocol improve the response to therapy in most cases, reducing tumor size and increasing the likelihood of organ-preserving surgery. In cases of lack of response to chemotherapy or disease progression, surgical treatment is considered. Surgical treatment should be performed in specialized centers. Genetic counseling is necessary to exclude BKT. There is a correlation between the histological variant of nephroblastoma and PS.
Zitieren
APA
Sagoyan, G. B., Mitrofanova, A. M., Suleymanova, A. M., Semenova, V. V., Rubanskaya, M. V., Gegeliya, N. V., Kerimov, P. A., & Varfolomeeva, S. R. (2026). Clinical, morphological and molecular genetic characteristics in patients with bilateral kidney tumors. Pediatric Hematology/Oncology and Immunopathology, 25(1), 114-130. https://doi.org/10.24287/j.1058
Vancouver
Sagoyan GB, Mitrofanova AM, Suleymanova AM, Semenova VV, Rubanskaya MV, Gegeliya NV, et al. Clinical, morphological and molecular genetic characteristics in patients with bilateral kidney tumors. Pediatric Hematology/Oncology and Immunopathology. 2026;25(1):114-130. doi:10.24287/j.1058
BibTeX
@article{Sagoyan2026,
author = {Sagoyan, G. B. and Mitrofanova, A. M. and Suleymanova, A. M. and Semenova, V. V. and Rubanskaya, M. V. and Gegeliya, N. V. and Kerimov, P. A. and Varfolomeeva, S. R.},
title = {Clinical, morphological and molecular genetic characteristics in patients with bilateral kidney tumors},
journal = {Pediatric Hematology/Oncology and Immunopathology},
year = {2026},
volume = {25},
number = {1},
pages = {114--130},
doi = {10.24287/j.1058}
}
EUVIMED